Our legal documents are maintained in English only to keep a single authoritative version.
1. About this website
This website provides general information about the IBDi remote-monitoring platform and the clinical studies in which it is currently used. It is intended for clinical, research, and implementation audiences interested in IBD care.
2. Not medical advice
Nothing on this website constitutes medical advice, diagnosis, or treatment recommendation. Patients should always follow the guidance of their own clinical team. The current IBDi version is used in live clinical studies and is not CE marked. It does not provide autonomous diagnosis, prediction, or treatment recommendations.
3. No self-enrolment
Access to the IBDi platform is linked to specific clinical study and clinic workflows. There is no open self-enrolment through this website.
4. Acceptable use
You agree not to misuse this website, attempt to access systems you are not authorised to access, or use the contact channel to transmit unlawful, harmful, or sensitive personal health information about yourself or others.
5. Intellectual property
The IBDi name, logo, written content, diagrams, and product imagery on this website are the property of IBDi and may not be reproduced without prior written permission, except for fair-dealing use such as journalism, academic citation, or quotation with attribution.
6. External links
This website may link to third-party websites, including healthcare and research organisations involved in the studies. IBDi is not responsible for the content of those external sites.
7. Changes to these terms
These terms may be updated as the project evolves and prepares for broader implementation. The most current version always applies to your use of the website.
8. Contact
For questions about these terms, contact the IBDi team via the contact page.
Draft for review: please verify with legal counsel before public launch.